Bharat Bio’s Telangana unit failed GMP test, led to Covaxin suspension: WHO

NEW DELHI: It was non-compliance with good manufacturing practices (GMP) at Bharat Biotech‘s flagship vaccine manufacturing facility at Hyderabad‘s Genome Valley that led to the World Health Organisation (WHO) suspending Covaxin supply for UN procurement.

Confirming this, WHO told TOI that the inspection it had carried out between March 14 and 22 “found that the manufacturing site for the production of the Covid vaccine Covaxin, located in Telangana, India, is not compliant with GMP and systemic issues need to be addressed”. “Problems were detected in some parts of the manufacturing process and changes were made after the EUL (emergency use listing) was granted but were not submitted to the national drug regulator and WHO for evaluation. The inspection was part of an campaign of manufacturing sites in India,” WHO said.

  • Related Posts

    • Pharma
    • July 22, 2025
    • 99 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    • Pharma
    • July 16, 2025
    • 492 views
    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

    Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end